Source: ESMO Open. Conference titles: ESMO Targeted Anticancer Therapies Congress. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, PERFILAÇÃO DA EXPRESSÃO GÊNICA, ONCOPROTEÍNAS
ABNT
TIEZZI, Daniel Guimarães et al. Molecular/genomic profile enhances prediction of response to target therapy in HER2-positive breast cancer. ESMO Open. Lugano: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.esmoop.2024.102318. Acesso em: 24 abr. 2026. , 2024APA
Tiezzi, D. G., Buono, F. de O., Fröhlich, A., & Pagnotta, S. M. (2024). Molecular/genomic profile enhances prediction of response to target therapy in HER2-positive breast cancer. ESMO Open. Lugano: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.esmoop.2024.102318NLM
Tiezzi DG, Buono F de O, Fröhlich A, Pagnotta SM. Molecular/genomic profile enhances prediction of response to target therapy in HER2-positive breast cancer [Internet]. ESMO Open. 2024 ; 9( S1):[citado 2026 abr. 24 ] Available from: https://doi.org/10.1016/j.esmoop.2024.102318Vancouver
Tiezzi DG, Buono F de O, Fröhlich A, Pagnotta SM. Molecular/genomic profile enhances prediction of response to target therapy in HER2-positive breast cancer [Internet]. ESMO Open. 2024 ; 9( S1):[citado 2026 abr. 24 ] Available from: https://doi.org/10.1016/j.esmoop.2024.102318
